Dedicated to being a pioneer for innovation in new drug development.
TaiRx, Inc. 2022-03-10T10:11:52+00:00

Information Related to Clinical Trials

TaiRx’s novel anti-cancer drug CVM-1118 and add-on therapy for sepsis drug Rexis® are currently in Phase II and Phase III clinical trials, respectively.

Clinical Trial of CVM-1118 on Hepatocellular Cancer

CVM-004

  • Center for Drug Evaluation, Taiwan:(Click here)
  • ClinicalTrials.gov:(Click here)

CVM-008

  • Center for Drug Evaluation, Taiwan:(Click here)
  • ClinicalTrials.gov:(Click here)

Clinical Trial of CVM-1118 on Neuroendocrine Tumors

CVM-005

  • Center for Drug Evaluation, Taiwan:(Click here)
  • ClinicalTrials.gov:(Click here)

Clinical trial of Rexis® as an add-on therapy for patients with sepsis and septic shock

MOFI-001

  • Center for Drug Evaluation, Taiwan:(Click here)

If you would like to know more information regarding the clinical trials, please contact the nearest clinical trial center.

News